Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5611 AL 5625

Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit

Pellicano C, Belvisi D, Bovenzi R, Costanzo M, De Bartolo MI, Sommaruga F, Blandino J, Modugno N, Piras F, Pierantozzi M, Stefani A, Fabbrini G, Schirinzi T.

J Neural Transm (Vienna). 2026 Mar;133(3):439-447. doi: 10.1007/s00702-025-03000-3. Epub 2025 Aug 31.

Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease

Desjardins C, Grimaldi S, Luo S, Yu L, Goetz CG, Stebbins GT, Martinez-Martin P, Kurtis MM, Mestre TA, Sanchez-Ferro A, Tosin MHS, Balestrino R, Lin CR, Gasca-Salas C, Witjas T, Colin O, Maltete D, Defebvre L, Giordana C, Charif M, Thiriez C, Laurencin C, Tir M, Dupont G, Remy P, Tranchant C, Drapier S, Samier A, Benatru I, Sambin S, Corvol JC, Khelifi F, Fabbri M, Rascol O; NS‐Part Cohort study group and the MDS COA Translation Steering Committee.

Mov Disord Clin Pract. 2026 Feb;13(2):575-579. doi: 10.1002/mdc3.70323. Epub 2025 Sep 1.

Validation of the Patient-Rated Version of the Parkinson Anxiety Scale in Iranian People with Parkinson's Disease

Mehdizadeh M, Eissazade N, Fereshtehnejad SM, Shati M, Mortazavi SS, Habibi SAH, Bayat M, Fendereski F, Akbari R, Taghavi Azar Sharabiani P, Taghizadeh G.

Clin Gerontol. 2026 May-Jun;49(3):596-604. doi: 10.1080/07317115.2025.2555573. Epub 2025 Sep 2.

COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion

Jenner P, Nyholm D.

J Neural Transm (Vienna). 2026 Feb;133(2):361-375. doi: 10.1007/s00702-025-03006-x. Epub 2025 Sep 2.

Progressive Supranuclear Palsy-A Global Review

Kukkle PL, Neupane R, Pantelyat A, Wills AM, Jabbari E, Dopper EGP, Kovacs GG, Hoglinger G, Aiba I, Litvan I, Ganguly J, Whitwell JL, Ma J, Okeng'O K, Skakibara R, Forrest S, Lorenzl S, Zewde YZ, Compta Y, Morris HR; MDS‐PSP Study Group.

Mov Disord Clin Pract. 2026 Mar;13(3):611-622. doi: 10.1002/mdc3.70338. Epub 2025 Sep 3.

Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review

Machado LS, Vidor P, Perquim L, Limberger C, Machado L, Rocha A, Soares C, Rahmouni N, S Brum W, Bellaver B, Ferreira PCL, Borelli WV, da Costa JC, Malpetti M, Pascoal TA, Souza DO, Edison P, Blennow K, Zetterberg H, Ashton NJ, Benedet AL, Serrano-Pozo A, Rosa-Neto P, Zimmer ER.

Mol Psychiatry. 2026 Jan;31(1):559-575. doi: 10.1038/s41380-025-03160-4. Epub 2025 Sep 4.

Language dysfunction as a primary feature of cognitive decline in neurological populations

Leavitt VM, Simani L, Haghighi AB, Koch M, König A, Rusz J.

J Neural Transm (Vienna). 2026 Mar;133(3):397-407. doi: 10.1007/s00702-025-03015-w. Epub 2025 Sep 6.

Abernethy Malformation Shunt Closure to Treat Hepatic Encephalopathy Mimicking Parkinson Disease

Padhi R, Prasannan A, Shethna V, Dhanasekaran J, Radhakrishnan SS.

J Vasc Interv Radiol. 2026 Jan;37(1):107826. doi: 10.1016/j.jvir.2025.08.043. Epub 2025 Sep 4.

Gait in Older People with Cognitive Impairments During Rhythmic Auditory Cueing: A Scoping Review

Msigwa S, Jane A, St George RJ, Michele L C.

Exp Aging Res. 2026 Mar-Apr;52(2):272-293. doi: 10.1080/0361073X.2025.2553072. Epub 2025 Sep 7.

New-Onset Psychosis in a Person with Parkinson's Disease after "Horny Goat Weed" Use

Deliz JR, Manoocheri K, Larson DN, Bega D.

Mov Disord Clin Pract. 2026 Feb;13(2):541-543. doi: 10.1002/mdc3.70350. Epub 2025 Sep 8.

[(18)F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson's disease: dosimetry and pharmacokinetics

Versweyveld L, Delva A, Cohilis M, Deroose CM, Van Weehaeghe D, Koole M, Vandenberghe W, Van Laere K.

Eur J Nucl Med Mol Imaging. 2026 Jan;53(2):1103-1112. doi: 10.1007/s00259-025-07517-3. Epub 2025 Sep 9.

Editorial for "Hemispheric Asymmetry of Neuromelanin-Iron Dysfunction in the Substantia Nigra: MRI-Based Evidence for Lateralized Motor Onset in Early-Stage Parkinson's Disease"

Martínez M, Ariz M, Alvarez I, Santoro TM, Castellanos G, de Solórzano CO, Pastor P, Pastor MA.

J Magn Reson Imaging. 2026 Jan;63(1):205-206. doi: 10.1002/jmri.70121. Epub 2025 Sep 10.

Is the Time Right to Start Testing if Late-Onset Depression is Associated With the Development of an α-Synucleinopathy Like Parkinson's Disease? A Double Systematic Review and Meta-Analysis

Booij J, Schalbroeck R, Wartenhorst M, van Hooijdonk CFM, Chahid Y, Cobben R, Dols A, Schutter N, Oudega ML, de Bie RMA, Cohen SE, Zantvoord J, Scheepstra K.

Am J Geriatr Psychiatry. 2026 Apr;34(4):611-623. doi: 10.1016/j.jagp.2025.07.014. Epub 2025 Aug 12.

In-vivo evidence of synucleinopathy in parkinsonism due to VCP mutation

Bonan L, D'Angeli D, Vacchiano V, Postiglione E, Incensi A, Valentino ML, Capellari S, Donadio V, Rizzo G, Liguori R.

J Neural Transm (Vienna). 2026 Mar;133(3):433-438. doi: 10.1007/s00702-025-03011-0. Epub 2025 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias